· QUICK SCAN

Validation & Qualification

Documented evidence the process consistently makes conforming product — and the systems behind it.

QMM · Technical ExcellenceGMPGood Manufacturing Practice
Assess this domain →
WHY IT MATTERS

Validation is documented evidence that a process, operated in a defined range, consistently produces conforming product; qualification proves the facility, equipment, and computerised systems support it. Gaps here are patient-safety gaps, so they draw intense inspection scrutiny — and the modern expectation is a lifecycle, not a one-time three-batch event.

WHAT GOOD LOOKS LIKE

The observable evidence a practitioner — or an inspector — would expect at each maturity level. Drawn from the assessment questions themselves.

How is your equipment and process validation program structured?

1Foundational

Validation performed on an ad hoc basis when required

2Defined

Validation Master Plan exists; coverage is incomplete

3Managed

Comprehensive VMP with defined scope, risk-based approach, and revalidation triggers

4Quantified

Lifecycle validation model per ICH Q8/Q9/Q10; continued process verification in place

5Optimized

Continuous process verification with PAT / real-time release; the validation lifecycle self-optimises against live process data

How are computer systems validated (CSV/CSA)?

1Foundational

No formal CSV program; systems used without validation

2Defined

Critical systems validated; program lacks consistency and inventory

3Managed

Risk-based CSV program with system inventory, validation plans, and periodic reviews

4Quantified

CSA approach aligned with ISPE GAMP5 (2022); data integrity controls documented and audited

5Optimized

Continuous assurance: automated risk-based testing, live data-integrity monitoring, and audit-by-exception across the system landscape

COMMON INSPECTION FINDINGS
  • Processes in routine commercial use without current, completed validation; no Continued Process Verification.
  • Validation Master Plan absent or incomplete; revalidation triggers undefined.
  • Computerised systems used without validation, or with audit trails disabled or never reviewed.
  • Acceptance criteria set after the fact, or not justified by process understanding (ICH Q8).
RECOMMENDED SPEQ RESOURCES
TEMPLATEValidation Master Plan ShellSTANDARD21 CFR Part 211
WHAT IT LOOKS LIKE WHEN IT FAILS — LIVE FDA RECALLS

Recent FDA recalls whose reason SPEQ maps to this domain — a SPEQ editorial interpretation of the recall reason, not an official FDA classification.

2026-07-22Class IIBell Pharmaceuticals, Inc

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

2026-07-22Class IIBell Pharmaceuticals, Inc

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

2026-07-22Class IIBell Pharmaceuticals, Inc

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

2026-07-22Class IIBell Pharmaceuticals, Inc

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

All recalls SPEQ maps to this domain →
ALL DOMAINS
Every maturity domain, decoded →
FDA QMM
How this rolls up to Technical Excellence →
THE FRAMEWORK
Where this domain sits in the operating model →